Mycobacterium smegmatis is an important model strain of Mycobacterium for scientific study because it is non-pathogenic and grows rapidly. However， research is limited by the low efficiency and time-consuming nature of existing genome editing tools. Although the Streptococcus pyogenes CRISPR-Cas9 system is widely used in bacterial genome editing， it cannot be introduced into M. smegmatis because of its toxicity. The authors test 14 different Cas effector proteins in M. smegmatis. Cas9 (TdCas9_m) from Treponema denticola， Cas9 (NmCas9) from Neisseria meningitidis， and Corynebacterium glutamicum codon-optimized Cpf1 (FnCpf1_cg) from Francisella tularensis do not affect cell growth. The numbers of transformant plasmids expressing TdCas9_m， NmCas9， or FnCpf1_cg， and guide RNAs (gRNA) targeting ku(MSMEG_5580)， ligD(MSMEG_6301)， pta(MSMEG_0783)， or ackA(MSMEG_0784) decreases by about 10-， 10-， or 100-fold， respectively， compared with plasmids expressing only the Cas effector proteins. Non-homologous end joining (NHEJ) is detected only in the CRISPR-FnCpf1_cg system. The one-plasmid-based， CRISPR-FnCpf1-assisted NHEJ system enables N iterative rounds of genome editing in 7N + 2 days， with an editing efficiency up to 70%; thus， this system should greatly reduce the necessary genome manipulation time for M. smegmatis.